Maximum DNA yield and stability ideal for research and banking.
- Ideal for self-collection
- 2ml saliva sample
- Compatible with automated decapping and sample handling
- New 600 series: compact tube design with 2D barcode and anti-rotation features for automation
Oragene•Dx saliva kits collect superior samples and improve patient care by providing a simple, painless alternative while removing the inconvenience, anxiety and cost of going to a clinic for a blood draw. Saliva sample collection also improves compliance rates, speeds up collection and extraction processes, and offers more options for transport and storage when compared to blood, rendering healthcare and genomic diagnostics more efficient.
Features:
- High quality, high quantity DNA †
- Non-invasive, reliable self-collection or assisted collection of samples
- DNA from saliva is a proven alternative to DNA from blood for downstream applications
- Increase donor compliance by 200% over blood collections
- Oragene•Dx nucleic acid stabilization chemistries are bacteriostatic, preventing human DNA degradation and inactivating SARS-CoV-2
- Samples remain stable at room temperature for one year, reducing storage and transport costs
- Compact form factor and robust sample stability across temperatures ranging from -20°C to 50°C increases sample transport options, including postal service
- Increase workflow efficiency and minimize sample handling with a standardized tube format and integrated 1D barcode
- Branding and customizable packaging available to create a unique end-customer experience
For in vitro diagnostic use. For collection of human DNA. Oragene•Dx has been cleared for in vitro diagnostic use in the U.S.A.
† FDA cleared for in vitro diagnostic use for direct-to-consumer applications, K192920. NOTE: Device / Assay manufacturers must validate the use of Oragene™•Dx for use with their device.
Benefits for the patient:
- Improved patient care, convenience and compliance with easy-to-use saliva based DNA sample collection
- Option to collect in clinic, at point-of-care, or at home with self-collection kits
- Oragene™•Dx and ORAcollect™•Dx saliva kits collect superior samples from all patients, including children or patients that have difficulty with traditional collection methods
Benefits for the lab:
- DNA Genotek’s sample collection products are validated to perform on a wide range of downstream in vitro diagnostic tests
- Increase efficiency, minimize sample handling and reduce handling errors with compatible formats for high-throughput processing
- Lab integration services available to optimize sample processing and reduce validation time and costs for genetic testing
Benefits for the test manufacturer:
- Speed time to market by leveraging FDA cleared DNA Genotek products and decrease overall cost structure
- High-quality biological sample collection products that are scientifically validated
- Access patient samples at point-of-care and eliminate the need for phlebotomy costs and infrastructure
- Improve efficiency, cut costs and increase the number of tests conducted by offering a completely non-invasive, regulatory compliant and easy-to-use saliva sample collection kits
- Leverage experience and expertise in customization , lab integration and sample management through DNA Genotek products and services
There is a rising global popularity of genetic testing, among healthcare professionals, academics, researchers, and lately consumers looking to improve health outcomes through personalized medicine. Use Oragene™•Dx and ORAcollect™•Dx saliva collection kits to collect high-quality DNA saliva samples in order to power Next Generation Sequencing (NGS) technologies for in vitro diagnostics and therapeutic health services.
Join our customer base of thousands using DNA Genotek, who offer a wide assortment of molecular diagnostic services including gene expression profiling, microarrays, CNV/SNP typing, pathogen detection, infectiou disease testing, pharmacogenetic testing, sample banking, assays for personalized medicine and custom diagnostics.
OGD-600 | Yield (µg) | Concentration (ng/µl) | A260/280 ratio |
Mean ± SD | 58.5 ± 47.0 | 68.1 ± 55.3 | 1.7 ± 0.1 |
Median | 48.4 | 55.3 | 1.7 |
95% of samples | ≥ 13.1 | ≥ 16.0 | 1.5 – 1.9 |
** Data obtained by testing 450 samples from 245 individuals